Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Barrett Esophagus 15 Esophageal Neoplasms 10 Colorectal Neoplasms 10 Rectal Neoplasms 7 Adenocarcinoma Of Esophagus 7 Stomach Neoplasms 6 Nasopharyngeal Carcinoma 6 Colonic Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Gastroesophageal Reflux 4 Polyps 3 Pathologic Complete Response 3 Neoplasms 3 Lung Neoplasms 3 Colorectal Neoplasms, Hereditary Nonpolyposis 3 Carcinoma 3 Precancerous Conditions 2 Hyperplasia 2 Fistula 2 Esophageal Squamous Cell Carcinoma 2 Carcinoma, Non-Small-Cell Lung 2 Adenomatous Polyposis Coli 2 Adenocarcinoma 2 Urogenital Neoplasms 1 Upper Tract Urothelial Carcinoma 1 Thyroid Neoplasms 1 Stomach Ulcer 1 Stomach Diseases 1 Signs and Symptoms 1 Sarcoma 1

Interventions

Gemcitabine 6 130-nm albumin-bound paclitaxel 4 S 1 (combination) 2 Radiosurgery 2 Oxaliplatin 2 Leucovorin 2 Fluorouracil 2 Electroporation 2 zimberelimab 1 surufatinib 1 Tomography, X-Ray Computed 1 Pancreatectomy 1 Irinotecan 1 Immunotherapy 1 Heavy Ion Radiotherapy 1 Endoscopy 1 Drug Therapy 1 Diagnostic Imaging 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Locally Advanced Pancreatic Cancer × Endoscopy × Clear all

NCT06944587 2025-04-25

NORPACT-3

Oslo University Hospital

Gastrointestinal

Locally Advanced Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡